Lanean...
Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China
Peripheral T-cell lymphoma (PTCL) is a set of rare and highly heterogeneous group of mature T- and NK-cell neoplasms associated with poor outcomes and lack of standard and effective therapies. The total number of newly diagnosed cases of PTCL yearly in China is estimated about 50,000. Chidamide (CS0...
Gorde:
| Argitaratua izan da: | Intractable Rare Dis Res |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995415/ https://ncbi.nlm.nih.gov/pubmed/27672541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2016.01024 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|